Literature DB >> 10082761

Transcriptional regulation of interleukin-2 gene expression is impaired by copper deficiency in Jurkat human T lymphocytes.

R G Hopkins1, M L Failla.   

Abstract

Copper deficiency reduces secretion of the cytokine interleukin-2 (IL-2) by activated rodent splenocytes, human peripheral blood mononuclear cells and Jurkat cells, a human T lymphocyte cell line. Previous studies showed that low Cu status also decreased the level of IL-2 mRNA in activated Jurkat cells by 50%. Synthesis of this cytokine is regulated by alterations in transcription of the IL-2 gene and the stability of IL-2 mRNA. To determine if Cu status influenced promoter activity of the IL-2 gene, Jurkat cells were transfected with a luciferase reporter gene construct containing the entire 300 bp human IL-2 promoter/enhancer sequence. Cu deficiency was induced by incubating stably transfected cells with the Cu chelator 2,3,2-tetraamine for 35 h prior to activating cells with phytohemagglutinin-P and phorbol myristate acetate. Luciferase activity in lysates of Cu-deficient cells was approximately 50% lower in several multiclonal and clonal cell lines of stably transfected cells than in replicate cultures that were not exposed to chelator. The relative levels of endogenous IL-2 bioactivity and luciferase activity were highly correlated in the transfected cell lines. The chelator-mediated reduction in reporter gene activity was dose-dependent at levels of 5-40 micromol 2,3,2-tetraamine/L. The addition of a slight molar excess of Cu, but not Zn or Fe, to medium containing 2,3,2-tetraamine prevented the decline in luciferase activity. IL-2 mRNA stability in parental Jurkat cells was independent of Cu status. These data indicate that decreased cellular Cu attenuates IL-2 synthesis in T lymphocytes by inhibiting transcription of the IL-2 gene.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082761     DOI: 10.1093/jn/129.3.596

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  7 in total

Review 1.  Exposure to Heavy Metals and Allergic Outcomes in Children: a Systematic Review and Meta-analysis.

Authors:  Jia Wang; Jiechen Yin; Xiang Hong; Ran Liu
Journal:  Biol Trace Elem Res       Date:  2022-01-10       Impact factor: 4.081

2.  Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis.

Authors:  Heejeong Kim; Hwa-Young Son; Sarah M Bailey; Jaekwon Lee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-18       Impact factor: 4.052

3.  Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.

Authors:  Myrna Hurtado; Umesh T Sankpal; Jaya Chhabra; Deondra T Brown; Rajasekhar Maram; Rafid Patel; Raj K Gurung; Jerry Simecka; Alvin A Holder; Riyaz Basha
Journal:  Invest New Drugs       Date:  2018-05-15       Impact factor: 3.850

4.  CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis.

Authors:  Mohammed S M Almuslehi; Monokesh K Sen; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Front Cell Neurosci       Date:  2020-03-10       Impact factor: 5.505

5.  Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis.

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Erika Gyengesi; Simon J Myers; Peter J Shortland; David A Mahns; Jens R Coorssen
Journal:  Cells       Date:  2019-10-24       Impact factor: 6.600

Review 6.  Development of copper based drugs, radiopharmaceuticals and medical materials.

Authors:  Paweł Szymański; Tomasz Frączek; Magdalena Markowicz; Elżbieta Mikiciuk-Olasik
Journal:  Biometals       Date:  2012-08-23       Impact factor: 2.949

7.  Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?

Authors:  Monokesh K Sen; Mohammed S M Almuslehi; Peter J Shortland; Jens R Coorssen; David A Mahns
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.